We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The European Trade Mark and Design Network has produced a common practice for use when assessing the inherent distinctiveness of figurative trade marks containing descriptive and/or non-distinctive words.
Frequently asked questions on the Levelling Up Fund Round 2.
Climate change is happening and is due to human activities; along with warming, many other changes are occurring such as melting polar ice, rising sea levels and more frequent floods, droughts and heatwaves.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Guidance for organisations when making decisions about the design and operation of enterprise IT services which handle OFFICIAL information.
Find out about the rules you must follow for spending, borrowing from, or transferring your charity’s permanent endowment.
Find out about the long-term effects some people can have after having COVID-19.
This guidance identifies common issues with validation and assessment of clinical trial applications and how to avoid them.
How to use a before-and-after study to evaluate your digital health product.
How to use a cost effectiveness analysis to evaluate your digital health product.
How to make a negligible value claim for unquoted shares, and how to check if shares previously quoted on the London Stock Exchange now have negligible value.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
How to register your medical devices with the Medicines and Healthcare products Regulatory Agency (MHRA) for the markets in Great Britain and Northern Ireland
This playbook explains how we use social media at GDS. In it, we share our best practice, what we've learned and what we're planning to do.
The Integrated Review has generated some misconceptions about the UK’s nuclear deterrent. Here are the answers to some of the most frequently asked questions.
The official report of all Parliamentary debates. Find Members, their contributions, debates, petitions and divisions from published Hansard reports dating back over 200 years.
Information for health professionals on the epidemiology, transmission and prevention of Chlamydia abortus which can cause stillbirth or abortion in humans.
Complete a draft or agreed statement of common ground
The latest reproduction number (R) and growth rate of coronavirus (COVID-19).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.